FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold

sirolimus-eluting bioresorbable scaffold · REVA Medical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold, covering 2025-04-04 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold [NA]

See pricing